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Abstract
 
Cytomegaloviruses (CMVs) deploy a set of genes for interference with antigen presentation in
the major histocompatibility complex (MHC) class I pathway. In murine CMV (MCMV),
three genes were identified so far: 
 
m04
 
/gp34, 
 
m06
 
/gp48, and 
 
m152
 
/gp40. While their func-
tion as immunoevasins was originally defined after their selective expression, this may not nec-
essarily reflect their biological role during infection. The three immunoevasins might act syner-
gistically, but they might also compete for their common substrate, the MHC class I
complexes. To approach this question in a systematic manner, we have generated a complete
set of mutant viruses with deletions of the three genes in all seven possible combinations. Sur-
face expression of a set of MHC class I molecules specified by haplotypes H-2
 
d
 
 (K
 
d
 
, D
 
d
 
, and L
 
d
 
)
and H-2
 
b
 
 (K
 
b
 
 and D
 
b
 
) was the parameter for evaluation of the interference with class I traffick-
ing. The data show the following: first, there exists no additional MCMV gene of major influ-
ence on MHC class I surface expression; second, the strength of the inhibitory effect of immu-
noevasins shows an allele-specific hierarchy; and third, the immunoevasins act not only
synergistically but can, in certain combinations, interact antagonistically. In essence, this work
highlights the importance of studying the immunosubversive mechanisms of cytomegaloviruses
in the context of gene expression during the viral replicative cycle in infected cells.
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Introduction
 
The capacity of a virus to actively modulate the host immune
response defines the biological balance between a persistent
virus and its host. A number of viral functions are instru-
mental for maintaining and tuning this balance. The highly
species-specific CMVs are a representative example. Hu-
man CMV (HCMV), a herpesvirus that defines the 
 
 
 
-her-
pesvirus subfamily, is an important pathogen only in the
immunologically immature or immunocompromised host,
whereas in the normal population the infection occurs
without clinical symptoms. CMVs interfere with innate
and adaptive cellular and humoral immune effector mecha-
nisms by affecting cytokine networks, by activation and si-
lencing of natural killer (NK)
 
*
 
 cells, by downmodulating
antigen presentation in the MHC class I and II pathways,
and by the regulation of apoptosis. Some viral genes that
affect host immune functions are homologues pirated from
the vertebrate genome, whereas others show no apparent
homology to host genes (1, 2).
Several HCMV and murine CMV (MCMV) gene prod-
ucts, usually glycoproteins, have been shown to interfere
with the MHC class I pathway of antigen processing and
presentation. With one exception, all these proteins inter-
fere with antigen presentation by downmodulation of
MHC class I cell surface expression. Individually, none of
those is essential for virus growth in cell culture. They lack
significant homologies to other herpesviral or cellular genes
and are dispersed over the left and right genome termini (3,
4). The HCMV proteins US2 and US11 cause proteasomal
degradation of MHC class I molecules by retrograde trans-
port from the ER to the cytosol (5, 6). The US3-encoded
protein binds to MHC class I molecules and arrests them in
the ER (7, 8). Finally, US6 binds to the peptide transporter
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associated with processing to prevent peptide loading of
MHC class I molecules (9–11).
MCMV is comparable to HCMV with regard to a vari-
ety of functions by which it can modulate the host re-
sponse. The infection of the mouse with MCMV offers
the advantage that defined mutants can be tested in the
natural host. In MCMV, three genes encoding glycopro-
teins that interact with MHC class I molecules, here re-
ferred to as immunoevasins, have been identified: the im-
munoevasin 
 
m04
 
/gp34 binds to MHC class I molecules
without affecting cell surface expression, which is excep-
tional for MHC class I interfering CMV proteins (12).
Nevertheless, 
 
m04
 
/gp34 is involved in the prevention of
antigen presentation to selected CTL clones by a so far un-
known mechanism (13). The second immunoevasin 
 
m06
 
/
gp48 reduces cell surface expression of MHC class I mole-
cules by binding them and by retargeting the complexes to
lysosomes for degradation (14). The third immunoevasin
 
m152
 
/gp40 also reduces cell surface expression of MHC
class I molecules, but achieves this by a different mecha-
nism, namely by retention of the peptide-loaded com-
plexes in the ER-cis-Golgi intermediate compartment
(15). The 
 
m152
 
/gp40 immunoevasin was the first and is
still the only MHC class I interacting CMV glycoprotein
shown to be relevant for CMV replication in vivo in the
face of functional immunity (16).
Previous studies on CMV-encoded MHC class I reactive
proteins have had the aim to elucidate the specific mode of
function of defined viral proteins. With the exception of
 
m152
 
/gp40 of MCMV, there exist no data on the rele-
vance of the individual immunoevasins in the course of
CMV infection in vitro and in vivo. It is unknown
whether, in the context of the CMV genome, the effects of
these genes are additive, cooperative, redundant, or even
competitive. Likewise, little is known about possible MHC
class I allele-specific differences in the action of the differ-
ent immunoevasins. This limited knowledge is because of a
lack of appropriate virus mutants that would allow to per-
form a systematic analysis of immunoevasin interactions in
the context of virus infection. The generation of CMVs
with targeted gene deletions by recombination in cells is la-
borious (17) and the generation of mutants with multiple
targeted mutations dispersed over the genome is almost not
achievable. Cloning of CMVs as infectious bacterial artifi-
cial chromosomes (BACs; reference 18) has opened per-
spectives for novel site–directed and random mutagenesis
techniques in 
 
Escherichia coli 
 
(for a review, see reference 19).
Further work from several laboratories on the generation
and mutagenesis of BAC-cloned CMV genomes (20–24)
has confirmed the attractivity and general applicability of
CMV mutagenesis in bacteria. Until now, targeted mu-
tagenesis usually involved subcloning of viral DNA and us-
age of available restriction sites, which is unfavorable for
the introduction of independent mutations in close prox-
imity (a distance of 
 
 
 
1.5 kbp; reference 18), as it is the case
for genes 
 
m04
 
 and 
 
m06
 
.
Here, we systematically investigated the influence on
MHC class I molecule surface expression of the immuno-
 
evasins 
 
m04
 
/gp34, 
 
m06
 
/gp48, and 
 
m152
 
/gp40 during
MCMV infection. We generated a complete set of
MCMV mutants which lack or express these three genes in
all possible combinations. To this end, we applied to the
viral MCMV-BAC a fast mutagenesis procedure for tar-
geted mutation via a double crossing-over event between
PCR-generated DNA fragments and the viral DNA. We
tested the effect of this set of seven MCMV immunoevasin
deletion mutants on cell surface expression of H-2
 
d
 
 and
H-2
 
b
 
 MHC class I alleles and conclude from the data the
following: (i) there exists no additional MCMV gene prod-
uct that would significantly interfere with MHC class I
molecule export; (ii) individual MHC class I alleles are dif-
ferentially affected; (iii) the isolated deletion of gene 
 
m06
 
has the strongest effect on MHC class I, indicating a domi-
nant role of the immunoevasin 
 
m06
 
/gp48; and (iv) the im-
munoevasins 
 
m06
 
/gp48 and 
 
m152
 
/gp40 cooperate in their
function. In contrast, 
 
m04
 
/gp34 and 
 
m152
 
/gp40 compete
for MHC class I molecules, whereby 
 
m04
 
/gp34 antago-
nizes the function of 
 
m152
 
/gp40. In summary, the viral
MHC class I–modulating proteins interact in their effects
on MHC class I molecules, and the outcome of this inter-
action is allele specific.
 
Materials and Methods
 
Cells, Viruses, and Plaque Assay.
 
BALB/c mouse embryonic
fibroblasts (MEFs) were cultured in DMEM supplemented with
10% (vol/vol) FCS, 100 U/ml penicillin, and 100 
 
 
 
g/ml strepto-
mycin. These cells were used for virus reconstitution from re-
combinant BAC plasmids as described previously (25). NIH3T3
cells (CRL1658; American Type Culture Collection) were cul-
tured in DMEM supplemented with 10% (vol/vol) newborn calf
serum and antibiotics (see above). These cells were used for prop-
agation of recombinant viruses, for determination of viral growth,
and for Western blot analysis. For the detection of MHC class I
molecules on the cell surface after infection with the respective
viruses, the following fibroblast cell lines were used: B12, which
is a BALB/c (haplotype H-2
 
d
 
)-derived SV40-transformed fibro-
blast cell line (26); and C57SV, which is a C57BL/6 (haplotype
H-2
 
b
 
)-derived SV40-transformed fibroblast cell line (27). The
MCMV wild-type (wt) and wt-like strains used in these studies
were strain Smith (VR-194; American Type Culture Collection)
and the BAC-derived recombinant MW97.01 (20). Virus stocks
were prepared following published protocols (28). In vitro
growth kinetics of the MCMV mutants and of parental wt
MCMV were determined on NIH3T3 cells as follows: NIH3T3
cells were infected with a multiplicity of infection of 0.1 PFU per
cell (without centrifugal enhancement) and supernatants of in-
fected cells were harvested every 24 h from day 0 (input virus ti-
ter) through day 5 after infection. Virus titers in supernatants
were measured in triplicate by a plaque assay performed on sec-
ond-passage MEF monolayers in 48-well plates as described pre-
viously (29).
 
Plasmid Construction.
 
Plasmid cloning was performed by stan-
dard methods (30). The parental shuttle plasmid pST76A-SacB is
a derivative of plasmid pST76A (31) into which the 
 
Bacillus amy-
loliquefaciens
 
 
 
sacB
 
 gene (32) was introduced. The 
 
sacB
 
 gene was
used for selection of clones with resolved cointegrates and lost
shuttle plasmids by adding 5% (wt/vol) sucrose to the agar plates
as described previously (21). The shuttle plasmid pSTm06, used 
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for generation of the BAC plasmid p
 
 
 
m06, was cloned as fol-
lows: the MCMV sequence from nt positions 2701–9760 was
excised from plasmid pHindIII A (33) by HindIII and KpnI di-
gestion, and was inserted into plasmid pBluescriptII (KS
 
 
 
) (Strat-
agene). Within this plasmid, the MCMV sequence from nt posi-
tions 5392–6235, containing open reading frame 
 
m06
 
, was
deleted by NheI treatment and replaced by the kanamycin resis-
tance gene (
 
kn
 
) from plasmid pCP15 (34). The MCMV se-
quence containing the 
 
kn
 
 instead of 
 
m06
 
 was then excised by
BstEII and EcoRI treatment and inserted into the SmaI site of
plasmid pST76A-SacB, hereby generating shuttle plasmid
pSTm06. Plasmid pSTm06 now contains the 
 
kn
 
 flanked by
MCMV sequences upstream (nt 2701–5392) and downstream (nt
6235–9760) of 
 
m06
 
.
 
Mutagenesis of Viral BAC Plasmids Using Linear PCR Frag-
ments.
 
A PCR-based mutagenesis procedure was used for the
generation of the recombinant MCMV BAC plasmids p
 
 
 
m04,
p
 
 
 
m152, p
 
 
 
m04
 
 
 
m06, p
 
 
 
m04
 
 
 
m152, p
 
 
 
m06
 
 
 
m152, and
p
 
 
 
m04
 
 
 
m06
 
 
 
m152 that contain exact single-, double- or tri-
ple-deletions of the MCMV open reading frames 
 
m04
 
, 
 
m06
 
, and
 
m152
 
, respectively. The technique was based on homologous re-
combination mediated by the recombination functions red
 
 
 
(exo) and red
 
 
 
 (bet), and the exonuclease inhibitor red
 
 
 
 (gam) of
bacteriophage 
 
 
 
 expressed from the plasmid pBAD
 
   
 
 (35) (for
the strategy, see Fig. 1 A). First, linear DNA recombination frag-
ments were generated. These fragments contained the prokary-
otic 
 
kn
 
 from plasmid pACYC177 (New England BioLabs) or the
resistance gene 
 
zeocin
 
 (
 
zeo
 
) from plasmid pZero1 (Invitrogen),
flanked by sequences of 40 to 60 nts in length, homologous to the
up and downstream regions of the target gene. For the generation
of these linear fragments by PCR, contiguous pairs of synthetic
primers were used, which all bind to the resistance gene with
their 3
 
 
 
-ends and which carry sequences homologous to the
MCMV genomic sequence at their 5
 
 
 
-ends. For deletion of gene
 
m152
 
 (nt 210244–211377), the PCR fragment m152-PCR, con-
taining 
 
zeo
 
 flanked by 34-bp minimal FRT sites (5
 
 
 
-GAAGTTC-
CTATTCTCTAGAAAGTATAGGAACTTC-3
 
 
 
), was gener-
ated by using plasmid pZero1 as template DNA and the
contiguous primers m152-FRT-zeo-5 (5
 
 
 
GCTCGAGCGAG-
AGCACCCGACGATCTGACATTGTCCAGTGTGCCGGT-
CGCACGAACATCAGAAGTTCCTATTCTCTAGAAAGT-
ATAGGAACTTCAACGTTTACAATTTCGCCTGATGCG-
3
 
 
 
) and m152-FRT-zeo-3 (5
 
 
 
TCACAAGCCGTGTCACCGC-
TCCACGTTTCACCGTCGTCGGTCTCCCGATCGCTA-
GCCTGAACAGAAGTTCCTATACTTTCTAGAGAATAG-
GAACTTCTGAAGTTTTAGCACGTGTCAGTCCT-3
 
 
 
). For
deletion of gene 
 
m04
 
 (nt 3270 to 4067), the PCR fragment
m04-PCR, containing 
 
kn
 
, was generated using plasmid pACYC-
177 as template DNA and contiguous primers m04–5 (5
 
 
 
-TAA-
TGATCTAGACGGCAATTTCTGTCTCATTCGTTGTTCC-
AGAGCGACGGATGGTACAAG-3
 
 
 
) and m04–3 (5
 
 
 
-TACT-
CAGAACACCGGAAAATGGTT TACTCAAGGGGATTTT-
TATTTAGGGGGTTAGTTACT-3
 
 
 
). With the exception of
the single 
 
m06
 
 deletion BAC plasmid p
 
 
 
m06 (see below), dele-
tion of the 
 
m06
 
 gene (nt 5300–6334) in the MCMV BAC plas-
mids was performed by using PCR fragment m06-PCR, which
was generated using plasmid pZero1 as template DNA and the
contiguous primers m06-
 
zeo
 
-5 (5
 
 
 
CACGCCCAAAATCAC-
GCAATCATATATAAATGGACAATGAAGCCAATCTAA-
CGTTTACAATTTCGCCTGATGCG-3
 
 
 
) and m06-
 
zeo
 
-3
(5
 
 
 
GCAGTCTAGCTAGCGGCTCGCGGCCGTAGGTGTA-
GAACAACATAGCACCTGAAGTTTTAGCACGTGTCAG-
TCCT-3
 
 
 
). The PCR products were purified using the QIAGEN
 
PCR purification kit (QIAGEN). For removal of residual meth-
ylated template plasmid DNA, products were digested with 20 U
of restriction enzyme DpnI for 1.5 h. The PCR products were
then immediately precipitated with 100% ethanol, washed with
70% ethanol, and resuspended in 10 
 
 
 
l of sterile water. 5 
 
 
 
l of
each linear fragment was electroporated into electrocompetent 
 
E.
coli
 
 (strain DH10B), containing the respective MCMV BAC plas-
mid and the recombination proteins (see below), using a Bio-Rad
Gene Pulser (2.5 kV, 200 
 
 
 
,
 
 and 25  F). After addition of 1 ml
of LB medium followed by shaking for 2 h at 37 C, the bacteria
were grown on LB agar plates containing 25  g/ml chloram-
phenicol and 25  g/ml kanamycin or zeocin and incubated over-
night at 37 C.
Electrocompetent DH10B were prepared as follows: 2 ng
DNA of plasmid pBAD    (45) was introduced into DH10B,
which contain the parental MCMV BAC plasmid, by chemical
transformation using standard protocols (30). 2 ml of an overnight
culture of these transformed DH10B were then added to 200 ml
of LB growth medium containing 25  g/ml chloramphenicol
and 25  g/ml kanamycin. 2 ml of 10% (wt/vol) L-arabinose in
LB medium was added at an OD600 of 0.2 in order to induce the
expression of the exo protein, which is controlled by the induc-
ible BAD-promoter (Invitrogen). After 30 min of incubation at
37 C, bacteria were put on ice for 15 min. After three washing
steps with ice-cold 10% (vol/vol) glycerol, bacteria were resus-
pended in a total volume of 800  l of 10% glycerol, subdivided
into 60  l aliquots, and frozen at  80 C.
Excision of the zeo from the MCMV BAC plasmid p m152-
zeo via the flanking FRT sites by FLP-mediated site specific re-
combination was performed by using plasmid pCP20 as described
previously (34).
Mutagenesis of BAC Plasmids Using Shuttle Plasmids. For dele-
tion of 82% of the m06 gene sequence (nt 5392 to 6235) within
the wt MCMV BAC plasmid pSM3fr, a two-step recombination
strategy based on RecA-mediated homologous recombination in
the E. coli strain CBTS (36) was applied as described previously
(18). Shuttle plasmid pSTm06 was used for the generation of the
recombinant MCMV BAC plasmid p m06 (Fig.1).
Reconstitution of Recombinant Viruses by Transfection. For re-
constitution of viral progeny, 80% confluent MEF in a 6-cm cul-
ture dish were transfected with 1.5  g of MCMV BAC plasmid
DNA by the calcium phosphate precipitation technique as de-
scribed previously (30). 5 h after transfection, the MEF were
treated with 15% glycerol (vol/vol) in Hepes-buffered saline for
2.5 min as described previously (30). After 3–5 d of cultivation,
virus plaques appeared. The recombinant viruses  m04-MCMV,
 m04 152-MCMV, and  m152-MCMV were already used
in a previous study and published under the names  m4-
MW99.03,  m4 m152-MW99.04, and  m152-MW99.05, re-
spectively (13).
Isolation and Analysis of DNA. Isolation of plasmid DNA
from E. coli cultures was performed using an alkaline lysis proce-
dure as described previously (30). Isolation of MCMV BAC
DNA from E. coli was performed using the Nucleobond kit from
Machery & Nagel. Viral DNA from infected cells was isolated as
published previously (33).
Western Blot Analysis. For protein detection in infected cells,
Western blot analysis was performed at 16 h after infection. For
the detection of m04/gp34, the specific peptide antiserum m04–3
(13) was used. The m152/gp40 protein was detected with mAb
gpM3D10 (37) and protein m06/gp48 was detected with poly-
clonal antiserum m06–2 (38). The lysates of virus-infected cells
were suspended in Laemmli sample buffer containing 5%  -mer-808 Interaction between Cytomegalovirus Immunoevasins
captoethanol, sonified for 10 s, and incubated at 95 C for 5 min.
After electrophoresis on a 10% SDS-PAGE, the proteins were
transferred to Hybond-P membranes (Amersham Biosciences) in
the presence of blotting buffer (25 mM Tris, 192 mM glycine,
20% [vol/vol] methanol, pH 8.3). After blocking of the mem-
branes for 30 min at room temperature with TBS-T (Tris-buf-
fered saline/0,05% Tween-20) containing 5% (wt/vol) dry milk,
the primary antibody was added in a dilution (in TBS-T) of
1:5,000. After washing with TBS-T, the membranes were incu-
bated with appropriate horseradish peroxidase-conjugated sec-
ondary antibody. Proteins were visualized using the ECL system
(Amersham Biosciences).
Flow Cytometry. For the detection of MHC class I molecules
on the surface of infected cells, the following antibodies were
used (see also Table I in Results): mAb 28–14–8s (HB27; Ameri-
can Type Culture Collection), specific for the  3 domain of
H-2Ld and Lq molecules, served for the detection of the Ld mole-
cule on cells of H-2d haplotype. mAb SF1.1.1 (HB-159; Ameri-
can Type Culture Collection) served for the detection of H-2Kd,
mAb 34–2-12s (HB-87; American Type Culture Collection) for
H-2Dd, mAb Y-3 (39) for H-2Kb, and mAb B22.249 (40) for
H-2Db. Subconfluent cell-layers in a 6-cm culture dish were in-
fected with recombinant or wt MCMVs with a virus dose of 0.3
PFU per cell using centrifugal enhancement of infectivity, which
results in an effective MOI of 6 (41). At 4, 7, 12 and 16 h after
infection, the cells were washed with PBS, trypsinized, and
rinsed with FACS®-buffer (PBS supplemented with 2% FCS and
0.03% [wt/vol] NaN3), followed by labeling for 60 min at 37 C
with the indicated primary antibodies. After washing with
FACS®-buffer, antibodies bound to MHC class I molecules were
stained by adding fluorescein-conjugated goat anti–mouse IgG
(Sigma-Aldrich).
A comparable infection rate for all wt and mutant viruses
( 90% of the cells infected) was confirmed for a separate aliquot
of the infected cells by labeling of the intranuclear viral IE1 pro-
tein pp89 with mouse mAb (IgG1) CROMA101 (provided by S.
Jonjic, University of Rijeka, Rijeka, Croatia). IE1 is expressed
during all kinetic phases of viral gene expression (42). For perme-
abilization of the cells, which is required for detection of intracel-
lular pp89, saponin was added to the buffers in a final concentra-
tion of 0.1% (vol/vol). Fluorescein-staining was performed as
specified above. Labeling of the cell surface marker CD44 with
rat mAb IM7.8.1 (TIB235; American Type Culture Collection)
was used to control for the expression of cell surface molecules
not affected by MCMV gene products in order to exclude down-
regulation of cell surface molecules due to a general cytopatho-
genic effect of the infection. For detection of antibodies bound to
CD44, fluorescein-conjugated goat anti–rat IgG (Sigma-Aldrich)
was used.
Throughout, cells incubated with the second antibody alone
were used as negative controls and the resulting fluorescence sig-
nals were subtracted from the values gained with the first and sec-
ond antibody for the same probes. For each expression profile,
3   106 or 5   106 cells were labeled and analyzed on a FACS-
Calibur™ (Becton Dickinson) using CELLQuest™ software
(Becton Dickinson) for data processing.
Assay for Competitive Virus Fitness In Vivo. Tissue tropism and
in vivo growth characteristics of wt MCMV and of the immune
evasion gene triple deletion mutant  m04 06 152-MCMV
were compared by coinfection of immunocompromised mice
followed by two-color in situ DNA hybridization (2C-ISH) of
viral genomes in infected tissues. In infected tissue cells, viral
DNA is accumulated during the late phase in an intranuclear in-
clusion body, which is the site of DNA packaging and nucleo-
capsid assembly.
Conditions of Infection. Female BALB/c mice (8-wk-old)
were immunocompromised by hematoablative total-body  -irra-
diation with a single dose of 7 Gy delivered by a 137Cs source. At
24 h after the irradiation, recipients were coinfected intrave-
nously in the tail vein with a 1:1 mixture (5   104 PFU each) of
the two MEF-propagated, sucrose-gradient purified viruses (41)
contained in 0.5 ml of physiological saline. Infection of host tis-
sues was determined by 2C-ISH on day 8 after infection, that is,
at a prefinal stage of multiple-organ CMV disease.
Hybridization Probes for 2C-ISH. The hybridization probe
M55-P spans 1541 bps from nucleotide positions 84250–85790
of the MCMV strain Smith genome (4) (GenBank/EMBL/
DDBJ accession no. MCU68299[complete sequence]) within the
gB-coding gene M55. It was synthesized by PCR using plasmid
pACYC-gB (43) as the template, and oligonucleotides 5 -
GCACGTCGTAGGTAAATTGC-3  and 5 -TCGCTCCTC-
GAGCTGGTACG-3  as primers. M55-P was tagged during the
PCR by incorporation of fluorescein-conjugated dUTP (fluo-
rescein-12-dUTP) (no. 1373242; Roche Laboratories). Probe
m152-P spans 1115 bps from nucleotide positions 210254 to
211368 within gene m152. It was synthesized by PCR using plas-
mid pGEM-4Z-m152 as the template, and oligonucleotides 5 -
CAGTTGATGTAGACCAGGCGATAC-3  and 5 -GCTAT-
CACCTACTTGCTCCTCTCG-3  as primers. For the con-
struction of pGEM-4Z-m152, the desired sequence within gene
m152 was amplified from virion DNA by using the primers men-
tioned above with their 5  ends extended by HindIII and BamHI
cleavage sites, respectively. The amplificate was then ligated into
cloning vector pGEM-4Z (GenBank/EMBL/DDBJ accession
no. X65305) (no. P2161; Promega). Probe m152-P was tagged
during the PCR by incorporation of digoxigenin-11-dUTP (no.
1093088; Roche Laboratories).
2C-ISH. A red label is used to visualize gene M55, which is
shared by the two viruses, whereas a black label is assigned to
gene m152 contained in the genome of wt MCMV only (for the
design, see Fig. 4 A). The hybridization of viral DNA in deparaf-
finized 2- m tissue sections was performed with procedures de-
scribed in greater detail by Grzimek et al. (44). In a first step,
gene M55 was stained red by using alkaline phosphatase-conju-
gated anti-fluorescein antibody (no. 1426338; Roche Laborato-
ries) with fuchsin as the chromogenic substrate. In the second
step, gene m152 was stained black by using peroxidase-conju-
gated antidigoxigenin antibody (no. 1207733; Roche Laborato-
ries) with diaminobenzidine tetrahydrochloride as the substrate,
followed by color enhancement with ammonium nickel sulfate
hexahydrate. Accordingly, cells infected by mutant  m04 
06 152-MCMV are marked by a clean red color, whereas in wt
MCMV the red staining of gene M55 is superimposed by the
black staining of gene m152. Quantitative microscopic analysis as
well as the photodocumentation of the tissue sections were per-
formed as described previously (44).
Results
Construction of Recombinant MCMV Genomes by PCR-
based BAC Mutagenesis in E. coli. To revisit the roles of
the known MHC class I interacting genes m04/gp34, m06/
gp48, and m152/gp40 in the course of infection, we in-
tended to generate a complete set of seven mutants with
single-, double-, and triple-deletions of these three genes in
all possible combinations. To this end, we applied to the809 Wagner et al.
MCMV-BAC a PCR-based one-step recombination pro-
cedure (45) using conditional expression of the proteins
red , - , and -  from bacteriophage   (Materials and
Methods and Fig. 1 for the mutagenesis strategy).
Using this procedure, six recombinant MCMV
BACs with deletions of the known immunoevasin genes
m04, m06, and m152 in all combinations were gener-
ated: p m04; p m152; p m04 06; p m04 m152;
p m06 m152; and p m04 m06 m152 (Fig. 1, B1–
B3). BAC plasmid p m06 was constructed by using the es-
tablished two-step recombination method (18) (Fig. 1 B4).
Correct deletions of the respective genes and the integrity
of the whole genomes were confirmed by restriction pat-
tern analysis using appropriate restriction enzymes followed
by Southern blot analysis (unpublished data).
Expression of Immunoevasins m04/gp34, m06/gp48, and
m152/gp40 by MCMV Recombinants. The MCMV BAC
plasmids p m04, p m06, p m152, p m04 m06, p m04 
m152, p m06 m152, and p m04 m06 m152 were
transfected into permissive MEF for the reconstitution of
viruses. The correct expression of gp34, gp48, and gp40 by
the MCMV mutants  m04-MCMV,   m06-MCMV,
 m152-MCMV,  m04 06-MCMV,  m04 152-MCMV,
 m06 152-MCMV, and  m04 06 152-MCMV, re-
spectively, was analyzed by Western blot analysis of lysates
from NIH3T3 cells infected for 16 h. All mutants showed
the expected pattern of glycoprotein expression (Fig. 2).
Immunoevasins m04/gp34, m06/gp48, and m152/gp40 Are
Collectively Dispensable for Virus Replication in Fibroblasts.
Previous work has already shown that each of the im-
mune evasion genes m04, m06, and m152 can be deleted
without affecting virus growth in fibroblast cell cultures.
However, since these genes could possibly substitute each
other in an essential function, deletion of all three or of
combinations of two might still abolish virus growth. In
addition, an impaired viral replication could result from
undesired spontaneous mutations that may have accumu-
lated elsewhere in the viral genomes during the repeated
mutagenesis procedures. To explore these possibilities, we
have taken multistep growth curves for wt MCMV and
the complete set of mutants (Fig. 3). Specifically,
NIH3T3 cells were infected at an MOI of 0.1 PFU per
cell (without centrifugal enhancement), and virus titers
in the supernatants were determined daily until day 5.
All mutants, including the triple-deletion mutant
 m04 06 152-MCMV, were found to grow like wt
MCMV. This finding excluded adverse effects of unde-
sired mutations and confirmed that the three immune
evasion genes are not essential for virus replication in fi-
broblasts in cell culture.
Figure 1. Strategy  for construction of t he
MCMV BACs and genomic organization of the re-
sulting deletion mutants. (A) Mutagenesis steps for
single-, double-, and triple-deletion of the MHC
class I interacting genes m04, m06, and m152 by
PCR-based BAC mutagenesis. By using primers
that contain 40–60 nucleotides homologous to the
up- and downstream regions of the viral target se-
quence at their 5 -ends (black boxes), FRT sites
(dotted boxes), and primer binding sites to a resis-
tance gene, a linear DNA recombination fragment
was amplified by PCR. This fragment was elec-
troporated into DH10B containing the MCMV
BAC with the chloramphenicol resistance gene
(Cm) and containing the recombination functions
red , - , and -  expressed from plasmid pBAD   .
Incubation under selection conditions results in re-
combinant MCMV BACs. These BACs were used
for the second round of mutagenesis using a differ-
ent resistance marker (marker 2). Alternatively, the
resistance marker could be excised by using FLP-
mediated recombination, leaving one residual FRT
site in the genome. This allowed the usage of the
same resistance marker for a further round of mu-
tagenesis. (B) Genomic organization of immune
evasion gene deletion mutants. Shown are the
HindIII fragments of the MCMV wt (strain Smith) genome. Genes m04 and m06, coding for the glycoproteins gp34 and gp48, respectively, are located
on fragment HindIII A. Gene m152, coding for gp40, is located on fragment HindIII E. (B1) In the first round of mutagenesis, the kn was inserted into
the BAC-derived wt MCMV genome MW97.01, thereby generating the mutant genome  m04-MCMV. Into this recombinant genome, the zeo gene
was additionally introduced, thereby deleting gene m152 and generating mutant  m04 152-MCMV. Since zeo was flanked by 34-bp FRT sites (cross-
hatched boxes), it could be excised by FLP-mediated recombination. This allowed again insertion of the zeo gene, this time for deletion of gene m06,
generating mutant  m04 06 152-MCMV. (B2) For the generation of mutant  m152-MCMV, gene m152 was replaced by a zeo gene that was
flanked by FRT sites. After FLP-mediated excision of zeo in position of m152, zeo was inserted once again for deletion of m06, generating mutant
 m06 152-MCMV. (B3) Mutant  m04 06-MCMV was generated by two rounds of recombination inserting the zeo in the place of gene m06 and
the kn in the place of gene m04. (B4) Mutant  m06-MCMV was generated by the two step replacement procedure using the shuttle plasmid pSTm06.810 Interaction between Cytomegalovirus Immunoevasins
The Triple Immunoevasin Deletion Mutant  m04 06 
152-MCMV Has No Growth Deficiency Phenotype in Immu-
nocompromised Mice. So far, the data have shown that the
three immune evasion genes, individually or in any possible
combination, are dispensable for virus replication in fibro-
blast cell cultures. Yet, in vivo, MCMV replicates in a wide
variety of cell types, including macrophages (46, 47), den-
dritic cells (48), endothelial cells, and different types of epi-
thelial cells such as hepatocytes, pneumocytes, enterocytes,
and glandular epithelial cells (49). Therefore, normal virus
growth in fibroblast cell cultures did not exclude an altered
cell type tropism and/or a modulated replication efficacy in
host organs. If interference with antigen presentation is the
only biological function of the immunoevasins, their dele-
tion in mutant  m04 06 152-MCMV should not affect
in vivo replication in absence of host immune functions.
For testing this prediction, we used here coinfection of se-
verely immunocompromised mice followed by quantitative
2C-ISH analysis of virus infection of host organs to directly
compare the in vivo fitnesses of wt MCMV and mutant
 m04 06 152-MCMV (Fig. 4). In essence, the mutant
was found to replicate at organ sites relevant to CMV dis-
ease, including liver (Fig. 4, B and C1), spleen (Fig. 4, B
and C2), adrenal glands (Fig. 4, B and C3), and lungs (un-
published data). Foci of infection in tissues, each represent-
ing the clonal progeny of a single hit infection event, were
either mixed black and red (representing wt MCMV) or
clean-red (representing the mutant). The existence of
clean-red foci proves that the mutant can replicate in the
respective tissues independent of wt MCMV. The histo-
morphometric quantitation of infected tissue cells indicated
an identical efficacy of wt and mutant virus spread in the
liver and the adrenal glands, whereas a minor disadvantage
of the mutant in the spleen may be attributed to some re-
sidual immunity in this lymphoid organ after the 7-Gy
 -irradiation. In conclusion, the data gave no indication for
a nonimmunological role of the immunoevasin genes.
Evidence Against the Expression of a Further MHC Class I
Downmodulating Immunoevasin during the E Phase. The
three currently known immune evasion proteins of
MCMV were identified by their interaction with MHC
class I molecules. In principle, there could have existed fur-
ther viral proteins performing such a function. The triple
mutant  m04 06 152-MCMV gave us the opportunity
to address that question for the first time.
Cell surface expression of a set of MHC class I molecules
specified by haplotypes H-2d and H-2b was tested by cyto-
fluorometric analysis using the cell lines and MHC allele-
specific antibodies compiled in Table I. As time point for
the analysis, we chose 12 h after infection, because this is an
E phase time at which all known immune evasion genes are
simultaneously expressed and at which expression of other
cell surface molecules, as verified for CD44 as a marker, is
not yet affected by cytopathic effects of the infection (tested
were 4, 7, 12, and 16 h after infection, unpublished data).
An infection rate of  90% of the cells was assured by the
detection of the intranuclear IE1 protein.
As it is shown in Fig. 5 A, cell surface expression of the
set of MHC class I molecules of haplotypes H-2d and H-2b
Figure 2. Expression of gp34, gp40, and gp48. NIH3T3 cells were in-
fected with the indicated viruses for 16 h or were left uninfected (mock).
The immunoevasin molecules were detected by Western blot analysis.
(A) Detection of gp48 with a polyclonal antiserum confirms lack of ex-
pression in all mutants with m06 gene deletion. (B) Detection of gp40
with a mAb confirms lack of expression in all mutants with m152 gene
deletion, and (C) detection of gp34 with a polyclonal antibody confirms
lack of expression in all mutants with m04 gene deletion. In mutants with
no deletion of m04, m06, and m152, respectively, expression of the corre-
sponding glycoprotein was confirmed.
Figure 3. Multistep virus growth curves in cell culture. NIH3T3 cells
were infected with the indicated wt and mutant viruses at an MOI of 0.1
PFU per cell and virus titers in the supernatants were detected every 24 h
after infection until day 5. All seven mutants show a virus productivity
comparable to wt MCMV (MW97.01).811 Wagner et al.
was essentially identical for uninfected cells and cells in-
fected with  m04 06 152-MCMV. This finding allows
the conclusion that there exists no further viral E gene that
would significantly contribute to the downmodulation of
MHC class I cell surface expression in the two MHC hap-
lotypes tested herein. Yet, it should be emphasized that the
existence of unknown functional analogs of m04/gp34,
which interact with MHC class I molecules but do not
downmodulate their cell surface expression, remains to be
considered.
The Efficacy of MHC Class I Downmodulation by the Con-
certed Action of All Three Immunoevasins Shows Allele-specific
Differences. With the rationale in mind that presence and
absence of all three immunoevasins would reveal the maxi-
mal possible difference, we compared MHC class I cell sur-
face expression after infection with wt MCMV and mutant
 m04 06 152-MCMV (Fig. 5 B). With the notable ex-
ception of Kb, the tested MHC class I molecules were sig-
nificantly downregulated by the three immunoevasins in
wt MCMV. The degree of downregulation was similar for
Kd, Dd, and Db, and a bit less for Ld. The finding that cer-
tain MHC class I molecules, Kb in the specific case, are ap-
parently not efficiently targeted by the immunoevasins,
predicts functional, allele-specific differences in the im-
mune control of infection.
Combinatorial Gene Deletions Reveal Synergistic As Well As
Antagonistic Interactions between the Immunoevasins. It is the
beauty of our immunoevasin gene deletion library of virus
mutants that immune evasion proteins can now be ex-
pressed in the context of infection in any possible combina-
tion (Table II).
Fig. 6 gives a comprehensive view on the effects of im-
munoevasins on the cell surface expression of all MHC
class I molecules specified by haplotypes H-2d (Fig. 6 A)
and H-2b (Fig. 6 B). Cytofluorometric analysis was again
performed at 12 h after infection, since, at that time point,
it was guaranteed that cells infected with the different vi-
ruses all expressed the corresponding immunoevasins. The
level of MHC class I surface expression observed was nor-
malized to the expression obtained after infection with
mutant  m04 06 152-MCMV. As shown above (Fig. 5
A), the expression was not significantly different in un-
infected cells and cells infected with  m04 06 152-
MCMV, but we preferred the mutant as the standard for
the data normalization to account for putative general ef-
fects of the infection on MHC class I gene expression, traf-
ficking, and metabolism.
Figure 4. Equivalent tissue tropism and comparable
in vivo replication efficacy of wt MCMV and mutant
 m04 06 152-MCMV in the absence of immune
control. (A) Maps (not drawn to scale) illustrating the
design of probes for two-color in situ hybridization
(2C-ISH), discriminating between wt (BAC-derived
MW97.01) MCMV (mixed black & red staining) and
mutant  m04 06 152-MCMV (clean-red staining).
(B) Comparative morphometric quantitation of infec-
tion in liver, spleen, and adrenal/suprarenal glands (per
mouse, only one of the paired glands was included in
the analysis) of immunodepleted (7Gy  -irradiated)
BALB/c recipients on day 8 after intravenous coinfec-
tion with wt MCMV and mutant MCMV. Note that
some adrenal glands were colonized clonally by either
wt or mutant MCMV. Shown are linked data pairs for
individual mice no. 1–5. Infected cells were counted
for representative 10-mm2 tissue areas, except for the
adrenal glands for which the results from 2-mm2 areas
were extrapolated to 10 mm2. (C1–C3) 2C-IHC–
stained sections of the indicated organs (derived from
individual mouse no. 5), showing distinct black-red or
clean-red foci of infection by wt and mutant MCMV,
respectively. Counterstaining was performed with he-
matoxylin. Bar marker, 100  m.
Table I. Compilation of Cell Lines and Antibodies Used for the 
Cytofluorometric Analysis of MHC Class I Cell Surface Expression
Cell line MHC haplotype Class I allele Antibody
B12 H-2d Kd SF1.1.1
B12 H-2d Dd 34-2-12s
B12 H-2d Ld 28-14-8s
C57SV H-2d Kb Y-3
C57SV H-2d Db B22.249812 Interaction between Cytomegalovirus Immunoevasins
Let us view the data in Fig. 6 from the left to the right.
At a glance, isolated expression of immunoevasin m04/
gp34 by mutant  m06 152-MCMV had no downmodu-
lating effect on the cell surface expression of any of the
tested MHC class I molecules. Rather, there appears to be
some upregulation in the case of Ld. Immunoevasins m06/
gp48 and m152/gp40, expressed by mutants  m04 152-
MCMV and  m04 06-MCMV, respectively, showed
comparable efficacy regarding the downmodulation of Dd,
Ld, and Db, whereas m06/gp48 was superior in downmod-
ulating K locus alleles, namely Kd and Kb. In addition, al-
lele-specific differences became apparent in that, for
instance, Dd was less affected than Db. Immunoevasin
m04/gp34, when coexpressed with m06/gp48 in mutant
 m152-MCMV, showed an indifferent role. It had no sig-
nificant influence on the expression of Kd, Dd and Db, but
instead of supporting downmodulation it rather appeared
to slightly antagonize the effect of m06/gp48 on Ld and Kb.
The most striking result was obtained after the coexpres-
sion of m04/gp34 and m152/gp40 in mutant  m06-
MCMV: m04/gp34 clearly antagonized the downmodulat-
ing effect of m152/gp40. Remarkably, this was true for all
five MHC class I molecules tested, including Kd, even
though gp34 was found not to form complexes with Kd at
the cell surface (12). In contrast, m06/gp48 and m152/
Figure 5. Cell surface expression of MHC class I
molecules. (A) Comparison between cells infected
with mutant  m04 06 152-MCMV and unin-
fected cells. (B) Comparison between cells infected
with wt MCMV (MW97.01) and cells infected
with mutant  m04 06 152-MCMV. The ex-
pression of MHC class I molecules of haplotypes
H-2d (Kd, Dd, and Ld) and H-2b (Kb and Db) was
measured by cytofluorometry at 12 h after infection
(multiplicity of infection of 6) of B12 and C57SV
cells, respectively. Left panels show original fluores-
cence histograms for one selected experiment.
Right panels show data compiled from 3 to 5 inde-
pendent experiments. The columns represent the
mean values (standard deviations indicated by bars)
of the percentage of expression relative to unin-
fected cells (in A) and relative to cells infected with
 m04 06 152-MCMV (in B).
Table II. Overview on the Expression of Immunoevasins by wt 
MCMV and the Set of Deletion Mutants
Virus
Immunoevasin molecule expressed
m04/gp34 m06/gp48 m152/gp40
 m04+06+152-MCMV     
 m06+152-MCMV     
 m04+152-MCMV     
 m04+06-MCMV     
 m152-MCMV     
 m06-MCMV     
 m04-MCMV     
wt MCMV     
Figure 6. Comprehensive patterns of MHC class I surface expression
for all possible combinations of immunoevasins expressed by the set of
immunoevasin gene deletion mutants. (A) Pattern for haplotype H-2d.
(B) Pattern for haplotype H-2b. B12 and C57SV cells, respectively, were
infected at an MOI of 6, and the expression of MHC class I molecules at
the cell surface was determined by cytofluorometry at 12 h after infection.
The columns represent the mean values (SDs indicated by bars) of the
percentage of expression relative to the expression in cells infected with
mutant  m04 06 152-MCMV (set as 100%) from 3 to 5 independent
experiments. The head legends indicate the combinations of immunoeva-
sins expressed by the various mutants (see Table II) and (farthest right col-
umn) by BAC-cloned wt MCMV MW97.01.813 Wagner et al.
gp40, coexpressed in mutant  m04-MCMV, showed a co-
operative function. This cooperation was particulary signif-
icant when single expression of either one was inefficient,
as it was the case for Dd. Finally, expression of all three
molecules in wt MCMV did not further enhance the coop-
erative downmodulation effected by m06/gp48 and m152/
gp40. Instead, in the case of Kb, the antagonizing function
of m04/gp34 was so strong that it partially rescued the sur-
face expression. Thus, our previous assumption that the
maximal downmodulation should be seen for wt MCMV
has found an exception in Kb.
In conclusion, this study has unraveled the effects of the
three MCMV-encoded immunoevasins on MHC class I
cell surface expression for two important, frequently stud-
ied haplotypes. The most important new finding is that the
immunoevasins interact not only in a cooperative but also
in a competitive fashion.
Discussion
Both, MCMV and HCMV deploy a set of genes to alter
stability and export of MHC class I molecules. These im-
mune evasion genes are unique for each virus and have dif-
ferent functional properties (50). Studies on the function of
individually expressed proteins have identified for each of
the seven MHC reactive CMV immunoevasins the princi-
ple of the interaction with the MHC class I molecule, the
intracellular compartment of activity, and the relevance of
viral protein domains (for a review, see reference 51).
The fact that each of the two viruses possesses multiple
genes for similar functions forces us to explain this apparent
redundance. Rapid MHC molecule degradation is the
dominant phenotype of HCMV infection, whereas destabi-
lization of nascent MHC class I complexes in the ER is
definitely not the hallmark of the MCMV gene functions.
The MCMV genes all affect the MHC complex export to
the plasma membrane. Therefore, in MCMV-infected
cells, but less so in HCMV-infected cells, the nascent
MHC class I complexes could interact with more than one
viral protein simultaneously or subsequently. Since the viral
proteins may have allelic preferences, this could result in a
complex pattern of allele-specific cooperative and competi-
tive effects. This might lead to results completely different
from what is seen when a viral protein is expressed and
tested in isolation.
Experimentally, this question can only be addressed by
construction and direct comparison of appropriate mutants
as a set. Until recently, the ability to mutate virus genomes
depended for most viruses on recombination techniques in
mammalian cells, a procedure which is difficult to control.
The advent of functional genomics has led to the develop-
ment of cloning vectors, suitable for the maintenance of
large inserts. These F-factor derived BACs fit perfectly to
the insert size requirements of herpesvirus genomes (120–
240 kb), and after pioneering MCMV BAC cloning by
our group (18), several herpesvirus genomes have been
successfully cloned as BACs. Since the large DNA inserts
in BACs preclude conventional enzymatic cleavage and li-
gation techniques, targeted BAC mutation in E. coli re-
quires sophisticated recombination procedures (for a re-
view, see reference 52). Here we adapted a recently
developed mutagenesis approach for manipulation of con-
ventional bacterial plasmids (45) to the viral BAC. This
method uses double crossing over of a linear DNA frag-
ment with the viral BAC mediated by the recombinases
red  and -  derived from bacteriophage   (53). Com-
pared with the conventional two-step shuttle mutagenesis,
the homologies required for efficient recombination are
reduced to only 25–50 nts. These short sequences can be
supplied by synthetic primers. This new strategy allows re-
peated mutagenesis of herpesvirus genomes without any
cloning and thus provided the basis for the construction of
the first systematic and comprehensive set of mutants for
multiple immunoevasins in the genomic context, the ma-
jor intention of this study.
By testing the growth of the MCMV mutants in cell
culture and in immunodepleted mice, we confirmed the
immunological nature of the attenuation phenotype and
the fidelity of the mutagenesis method. The in vivo repli-
cation is an important control, as it can reveal even subtle
differences in virus fitness. According to our results, mu-
tants that have undergone repeated mutagenesis procedures
are not unspecifically attenuated and therefore can reliably
be used in future in vivo studies on immune control and
immune evasion.
Here, we focused on the hallmark of MHC class-I–
interfering functions, namely the surface expression of MHC
class I molecules. We used cytofluorometric analysis, be-
cause this method is sufficiently standardized and reproduc-
ible to identify consistent patterns between large scale ex-
periments performed with different cell lines. Three major
findings are emerging: first, only the previously identified
immunoevasins  m06/gp48 and m152/gp40 downmodu-
late surface expression of MHC class I molecules after in-
fection of cells with MCMV. Our data exclude the exist-
ence of additional unknown MCMV genes that would
indirectly affect MHC molecule stability, as it is the case in
HCMV for gene US6 which inhibits transporter associated
with processing–dependent peptide translocation into the
ER and loading of MHC molecules (9–11).
Second, the third known immunoevasin, namely m04/
gp34, operates in an essentially different fashion in that it
does not downmodulate MHC class I cell surface expres-
sion, although it binds to MHC class I molecules in the ER
as well as at the cell surface (54). This is consistent with our
original hypothesis that m04 contributes only indirectly to
immune evasion, for instance through NK control (12).
Since cell surface expression was the parameter tested in
our study, the data cannot rule out the existence of further
immunoevasins that function like m04/gp34. Data pre-
sented here indicate that gp34 destines MHC complexes
for export to the plasma membrane. This does not yet ad-
dress the functionality of the MHC molecule complexed
with m04/gp34. One consequence of m04 expression in
cells of H-2d haplotype is the presentation of an antigenic814 Interaction between Cytomegalovirus Immunoevasins
peptide of m04/gp34 itself (55). Studying the recognition
of MCMV-infected cells by CTL clones in the H-2b hap-
lotype, we observed that m04/gp34 compromises Kb- but
not Db-restricted CTL clones by an as yet unknown mech-
anism (13). Thus, although the surface export of MHC
molecules is not negatively affected, the binding site for the
TCR or the cargo of peptides might be different for MHC
molecules escorted by m04/gp34.
Third, and most striking, the immunoevasins have coop-
erative as well as antagonistic effects with regard to surface
expression of MHC molecules. Whether or not there is a
hierarchy in the strength of MHC downregulation of m06
over  m152 must await further MHC molecule testing.
Clearly, m06/gp48 and m152/gp40 do cooperate to reduce
MHC class I expression. This becomes detectable when
molecules such as Dd are analyzed, which are not strongly
regulated by either of these two immunoevasins when ex-
pressed in isolation. Therefore, the redundance may be
helpful to effectively downregulate MHC alleles in cases in
which each individual immunoevasin has only a limited ef-
fect. The moderate effect of the isolated m152 in the ge-
nomic context comes as a surprise, given the fact that
deletion of m152 has strong functional effects on CTL
recognition of antigenic peptides presented by MHC mol-
ecules such as Ld (16), Kb, and Db (13). The finding that
m152 does have effects on CTL recognition which do not
completely parallel with its effects on the modulation of
MHC expression at the plasma membrane suggests that this
gene may affect CTL function through more than one
mechanism. Our recent finding that m152/gp40 has dual
effects in that it, besides MHC class I downregulation, also
downmodulates H-60, thereby downregulating NK cell
function and possibly also accessory CTL functions, pro-
vides an explanation (56). Therefore, we have to be careful
with regard to functional predictions based on the amount
of MHC molecules at the cell surface. In fact, the role of
m06 is less stringently corroborated by functional testing,
and future analysis of the mutants will have to show
whether m06 can control CTL recognition to the extent
predicted by its effect on MHC export (14).
Remarkably,  m04/gp34 antagonizes and overrides the
downmodulating effect of m152/gp40 for all MHC class I
molecules tested. As this effect is seen only after deletion of
gene m06, a situation which is unlikely to exist in a natural
MCMV genome, one apparent role of immunoevasin
m06/gp48 is to prevent an m04/gp34-mediated restoration
of class I surface expression.
In contrast, m04/gp34 did not antagonize the down-
modulating effect m06/gp48. There must exist a structural
basis for this difference: in accordance with the gene ex-
pression kinetics, m06 gets the first chance to interact with
MHC class I, since even for an MHC molecule such as Dd,
for which the downmodulation by m06/gp48 is incom-
plete, the subsequent expression of the m04 gene cannot
revert the inhibition (Fig. 6). One should consider that
there is stable complex formation between viral immuno-
evasins and MHC class I molecules only for m04/gp34 (12)
and m06/gp48 (14) but not for m152/gp40. m152/gp40 is
the earliest immunoevasin to be expressed during the viral
replication cycle (15) but its interaction with MHC class I
molecules is only transient. Nevertheless, after interaction
with m152/gp40 expressed in isolation, MHC molecules
lose the intrinsic capacity to migrate to the plasma mem-
brane (37). Most probably, the nascent molecules get their
irreversible destination by the interaction with either m06/
gp48 or m04/gp34, resulting in lysosome or plasma mem-
brane targeting, respectively, whereas the interaction with
m152/gp40 does not determine the final fate of the MHC
complexes. Therefore, it is not unreasonable to speculate
that in the absence of m06/gp48 at least some of the MHC
complexes that were originally retained in the ER by
m152/gp40 are eventually escorted to the cell surface by
m04/gp34, whereas in the presence of m06/gp48 the
MHC class I traffic is preferentially directed toward lysoso-
mal degradation.
In summary, the testing of a set of immune evasion gene
mutants has disclosed functional interactions between im-
munoevasins. With the new mutagenesis methods, virus
constructs can be generated in the near future in which by
promoter exchange the expression of immunoevasins is al-
tered from synchronous to sequential or even conditional
expression patterns in order to study the temporal regulation
of immunoevasin interactions. This study has already re-
vealed that, with respect to MHC class I surface expression,
the function of one immunoevasin, namely m04/gp34, is
strongly antagonistic to m152/gp40, another immunoevasin
encoded in a distant region of the viral genome.
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